Drug
Dotinurad
Dotinurad: highest development phase Phase 3, developed by Crystalys Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Crystalys Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Dotinurad NCT07089875 | Phase 3 | Gout |
| Dotinurad NCT07089888 | Phase 3 | Tophaceous Gout |
Latest
No recent events.
Follow Dotinurad on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.